Measurement of Post Challenging Immune Response (Serum?s Th1, Th2 Cytokines and Spleen?s CD Markers) with L.Major Amastigote in Balb/c Mice
Journal Title: Journal of Clinical & Cellular Immunology - Year 2023, Vol 14, Issue 2
Abstract
Introduction: Leishmaniasis is a disease caused by the Leishmania major parasites and afflicted a large number of people every year. This disease is immunologically complex and in some cases, spontaneous improvement is achieved but in some others it enters the systemic phase. Therefore, it seems that the preparation of the vaccine is best suited to combat the disease. Materials and methods: In this study, Balb/ C mice were vaccinated with new leishmaniasis vaccine and received booster dose one week later. Balb/c mice were challenged 1 week after booster dose. Almost 5 weeks later mice sacrificed. Final stages of preparation of the new L. major vaccine were evaluation of immunologic parameters in three injection groups (LT, LB and LBT) and two injection doses (100, 200 μg/0.1 ml) (totally six groups) post challenge with amastigote which removed from the wound (efficacy) and control group. Efficacy was measured by mice survival rate. Results and discussion: In this study, the highest IL-4, IFN-γ and CD3+ ,CD4+ , CD8+ and CD25+ were related to the LT group and highest IL-10 and IL-12 were also related to the control group. So it looks like that LT was best injection group and 100 and 200 μg/0.1 ml were best injection doses which recommended for future researches.
Authors and Affiliations
Afshineh Latifynia Mohammad Hossein Nicknam Mohammad Javad Gharagozlou Samad Farashi Bonab Bita Ansaripour Soror Charedar
Keywords
Related Articles
- EP ID EP741767
- DOI 10.35248/2155-9899.23.14.681
- Views 52
- Downloads 0
The Pattern of CD4+ T Cell Recovery and Determinants of HIV Infected Individuals Receiving Highly Active Antiretroviral Treatment in Mekelle Hospital, Tigray Northern Ethiopia: A Retrospective Study
Background: With the development of antiretroviral treatment, the incidence of HIV-related illness and death has significantly decreased. Nevertheless, some individuals living with HIV who are taking Anti-Retroviral Ther...
Hyper IgM Syndromes: A Brief Review of the Pathogenesis, Clinical Features and Management
Primary Immuno Deficiency (PID) disorders are heterogeneous disorders of the innate or the adaptive immune system, leading to recurrent infections that can also predispose to autoimmune diseases and malignancies. Hyper I...
Secretory IgA and Course of COVID-19 in Patients Receiving a BacteriaBased Immunostimulant Agent in Addition to Background Therapy
Background: Mucosal immunity plays a major role not only in the prevention but probably also in the outcome of COVID-19. An enhanced production of secretory Immunoglobulin A (sIgA) might contribute to the activation of t...
Exercise-Mediated Immune Protection in Chronic Kidney Disease Decreases Infection and Severe Evolution of COVID-19
It is constantly sought to understand the different mechanisms of action of the immune system to establish potential efficient therapeutic targets for different clinical situations. Thus, the present study aims to expand...
Assessing the Fidelity of the Malaria Vaccine Implementation in Malawi
Globally, remarkable progress has been made in the fight against malaria over the last two decades, yet the rate of reduction of malaria case incidence and mortality seems stalled. Globally, malaria case incidence (i.e.,...